ENTITY
Eris Lifesciences

Eris Lifesciences (ERIS IN)

36
Analysis
Health CareIndia
Eris Lifesciences Limited manufactures, markets, and sells generic drugs. The Company focuses on cardiology, diabetology, endocrinology, gastroenterology, ENT, orthopedics, pediatrics, and gynecology segments. Eris Lifesciences distributes pharmaceutical drugs throughout India. v
more
Refresh
bullishMankind Pharma
19 Apr 2023 12:18

Mankind Pharma IPO - Quality Name but Might Not Have a Whole Lot of Upside

Mankind Pharma (MP) is looking to raise up to US$527m in its upcoming India IPO. In this note, we talk about the implied valuations.

Logo
386 Views
Share
19 Apr 2023 10:51

Indegene Pre-IPO - Growing Client Base and Cross/Up-Selling Led to Growth

Indegene Limited (1864095D IN) is looking to raise about US$400m in its upcoming India IPO. Indegene is a “digital-first” commercialisation firm...

Logo
428 Views
Share
bullishMankind Pharma
18 Apr 2023 17:04

Mankind Pharma Pre-IPO - RHP Updates - A Mixed Bag

Mankind Pharma  (MP) is now looking to raise around US$500m in its upcoming India IPO. In this note we talk about the updates from its recently...

Logo
340 Views
Share
16 Mar 2023 10:50

Blue Jet Healthcare Pre-IPO - Marquee Clients but Inconsistent Growth and Margins

Blue Jet Healthcare Ltd (BJHC IN)  is looking to raise about US$300m in its upcoming India IPO. In this note, we talk about the past performance.

Logo
453 Views
Share
bullishMankind Pharma
09 Feb 2023 10:55

Mankind Pharma Pre-IPO - Thoughts on Valuations

Mankind Pharma  is looking to raise about US$1bn in its upcoming India IPO. In this note, we will talk about valuations.

Logo
362 Views
Share
x